Peptide Academy · Growth

Modified GRF 1-29

Also known as Mod GRF / CJC-1295 without DAC

Educational research summary, not medical advice. Many compounds here are not approved for human use. Talk to a licensed clinician before making any health decision.

The Peptide Academy is free to read. Members also get the research protocols for Modified GRF 1-29, dose and vial tracking, and an AI Advisor with cited sources. Try it all free for 7 days, no card needed.

Start my free 7-day trial

What is Modified GRF 1-29?

A stabilized short GHRH fragment producing pulsatile GH release without albumin binding.

How it works

Four amino-acid substitutions protect GHRH(1-29) from DPP-IV cleavage, extending half-life to ~30 minutes while preserving pulsatility.

Published research

Standard pairing partner for GHRP-class secretagogues in research protocols

Cautions

May raise fasting glucose; avoid with active malignancy.

Side effects & fixes

Common side effects

—Facial flushing or a warm, tingly feeling 5–15 minutes after injecting
—Headache or lightheadedness
—Water retention or puffiness in the first 1–2 weeks
—Tingling or numbness in the hands (carpal-tunnel-like) at higher exposure
—Increased hunger (strongest with GHRP-6 and MK-677)
—Higher fasting blood sugar with longer use

Histamine reactions

Common. The post-injection flush, redness and itch — most noticeable with CJC-1295 and GHRPs — is a histamine-type response that usually passes within 30–60 minutes.

Common fixes

Inject slowly and consider a lower dose; the flush is dose-related.
Dosing at bedtime means most of the flush happens while you sleep.
For mild itching, redness or flushing, a non-drowsy over-the-counter antihistamine (such as cetirizine or loratadine) is commonly used — check with a pharmacist first, especially if you take other medicines.
Cut back on salt and drink more water for puffiness; it usually settles after the first couple of weeks.
Reduce the dose if hand tingling or numbness appears.
If you can, check fasting glucose periodically, especially on MK-677 or long cycles.

Stop and get help

Numbness or weakness that does not fade after lowering the dose.
Stop and get emergency help for swelling of the face, lips, tongue or throat, trouble breathing, widespread hives, chest pain or fainting.

Basis: Clinical studies and consistent community reports for GH secretagogues. Educational only, not medical advice.

Medication concerns

Theoretical: no human interaction studies

Insulin, metformin and other diabetes medicines
Growth hormone lowers insulin sensitivity, so blood sugar can rise and diabetes doses may need adjusting.
Steroid replacement (hydrocortisone, prednisone) for adrenal insufficiency
Growth hormone can lower cortisol activity; people on replacement may need a higher maintenance or stress dose.
Thyroid medicine (levothyroxine)
Growth hormone can unmask an underactive thyroid or change thyroid needs; thyroid labs are usually rechecked.
Medicines or supplements that raise prolactin or cortisol (antipsychotics like risperidone, metoclopramide)
GHRP-2, GHRP-6, hexarelin and MK-677 can raise cortisol and prolactin themselves; effects may stack.
Everything else you take, including supplements
Bring a full list of medicines and supplements to your pharmacist or clinician before starting.

Basis: No interaction studies for these research secretagogues; concerns follow from the growth hormone they release (somatropin label). Educational only, not medical advice. Never stop or change a prescribed medicine without your prescriber.

Protocols & tracking are members-only

Members see the research protocols for Modified GRF 1-29, plan schedules, track every dose and vial, and ask the AI Advisor questions with cited sources. Try every Researcher feature free for 7 days, no card needed.

Start my free 7-day trial Reconstitution calculator

More growth compounds

Browse all compounds in the Peptide Academy →